Showing results (131-140 of 437) with videos related to
Sort By:
Pageof 44
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|May 12, 2020
[CT imaging features of patients with different clinical types of COVID-19]Qi Zhong, Zhi Li, Xiaoyong Shen, et al.Pharmacological Research|June 26, 2021
Non-cytomembrane PD-L1: An atypical target for cancerHonggang Ying, Xiaozhen Zhang, Yi Duan, et al.Biomedical Materials (Bristol, England)|March 29, 2023
A tumor microenvironment-stimuli responsive nano-prodrug for overcoming gemcitabine chemoresistance by co-delivered miRNA-21 modulatorFu Zhang, Zhuo Yao, Piaopiao Jin, et al.Analytica Chimica Acta|December 27, 2008
Integrated analysis of serum and liver metabonome in liver transplanted rats by gas chromatography coupled with mass spectrometryYi Wang, Yi Tao, Yunjin Lin, et al.Omics : a Journal of Integrative Biology|February 7, 2009
Metabonomic profile of rats with acute liver rejectionYi Wu, Yi Tao, Liang Liang, et al.Studies in Health Technology and Informatics|January 25, 2024
Position Prior Attention Network for Pancreas Tumor SegmentationKaiqi Dong, Peijun Hu, Xiang Li, et al.Cancer Letters|December 3, 2014
AFP (alpha fetoprotein): who are you in gastrology?Wenhui Sun, Yong Liu, Dawei Shou, et al.Cancer Letters|August 2, 2025
Bacteria and tumor debris induced pancreatic cancer progression via the NF-κB signaling pathwayQi Chen, Yonghao Xu, Yisu Wang, et al.Studies in Health Technology and Informatics|August 8, 2025
Utilization of Whole Slide Pathological Images and Tumor Clinical Data: A Hybrid Graph Convolutional Network Model for Hepatocellular Carcinoma Prognosis PredictionBoyang Deng, Yu Tian, Qi Zhang, et al.Biomaterials Science|March 10, 2026
Correction: Tumor-triggered personalized microRNA cocktail therapy for hepatocellular carcinomaShiyi Shao, Qida Hu, Wangteng Wu, et al.Pageof 44